Key facts
- Notable investors include Tech Incubator Program for Startup, Korea Investment Partners, IBK Changgong, Korea Credit Guarantee Fund, D-Camp — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for iMedTech
- ·The full record, as it builds
Funding rounds
No funding rounds for iMedTech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About iMedTech
Manufacturer of regenerative medical devices intended to improve patient treatment through biomedical engineering. The company offers bio-interface technology, nanofiber-based materials, and automated manufacturing, enabling healthcare providers in tissue repair to support recovery and treatment efficiency.
- Sector
- Healthcare
- HQ
- Gwangju, South Korea
- Founded
- 2023
- Employees
- 25
- Website
- imeditech.kr/
- Ownership
- Privately Held (backing)
iMedTech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in iMedTech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on iMedTech in its N-PORT filings yet. We sweep new filings monthly.